Maple Drug Substances And Products Private Limited, a active private limited company, was established on 14 September 2020 in Hyderabad, Telangana, India. Engaging in medical & laboratory equipment within the healthcare sector, it holds CIN: U33110TG2020PTC143892. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Its leadership includes Harsha Vardhan Nandepu (Director), Hardev Nandepu (Director), Venkateswara Rao Nandepu (Director). It holds ₹60.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 7-1-638 To 643, 643/1, Flat No. 302, Beside Esi Hospital, Erragadda,, Hyderabad, Telangana, 500038.
U33110TG2020PTC143892
143892
14 September 2020
₹1.00 M
₹1.00 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Maple Drug Substances And Products Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Harsha Vardhan Nandepu | Director | 14 Sep 2020 | Current |
| Hardev Nandepu | Director | 14 Sep 2020 | Current |
| Venkateswara Rao Nandepu | Director | 14 Sep 2020 | Current |
| Veera Venkata Rama Vijayalakshmi Nandepu | Director | 14 Sep 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Maple Drug Substances And Products Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 30.9% increase in profit. The company's net worth dipped by a decrease of 4.69%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Maple Drug Substances And Products's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹600,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Dec 2024 | Others | ₹60.00 Cr | Open |
Explore comprehensive loan charge details -
Maple Drug Substances And Products has a workforce of 0 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Maple Drug Substances And Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maple Drug Substances And Products's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Others amounted to Rs. 600.00 M with Charge ID 101020521 was registered on 10 Dec 2024. was completed.
The activity Maple Drug Substances And Products Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Maple Drug Substances And Products Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
The activity Harsha Vardhan Nandepu was appointed as a Director was appointed as a Director on 14 Sep 2020 & has been associated with this company since 5 years 2 months . was completed.
Progress on Hardev Nandepu was appointed as a Director was appointed as a Director on 14 Sep 2020 & has been associated with this company since 5 years 2 months . was documented.
Progress on Venkateswara Rao Nandepu was appointed as a Director was appointed as a Director on 14 Sep 2020 & has been associated with this company since 5 years 2 months . was documented.
The CIN of Maple Drug Substances And Products Private Limited is U33110TG2020PTC143892.
Maple Drug Substances And Products Private Limited is headquartered at 7-1-638 To 643, 643/1, Flat No. 302, Beside Esi Hospital, Erragadda,, Hyderabad, Telangana, 500038.
Maple Drug Substances And Products Private Limited was incorporated on 14 September 2020.
The current directors of Maple Drug Substances And Products Private Limited are
The primary industry of Maple Drug Substances And Products Private Limited is Healthcare.
Maple Drug Substances And Products Private Limited is unlisted.
The authorized capital of Maple Drug Substances And Products Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX